Ocular Therapeutix Downgraded to Neutral from Buy at H.C. Wainwright
December 28, 2020 at 09:26 AM EST
H.C. Wainwright analyst Yi Chen downgraded Ocular Therapeutix to Neutral from Buy without a price target. The analyst cites valuation and "near-term market uncertainty" for the downgrade.